Skip to main content
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in:

17-10-2022 | Hepatocellular Carcinoma | Correction

Correction: Comparing Predictability of Non‑invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients

Authors: Yen-Chun Liu, Ya-Ting Cheng, Yi-Cheng Chen, Yi-Chung Hsieh, Wen-Juei Jeng, Chun-Yen Lin, Rong-Nan Chien, Dar-In Tai, I.-Shyan Sheen

Published in: Digestive Diseases and Sciences | Issue 2/2023

Login to get access

Excerpt

The original version of this article unfortunately contained a mistake in the article title. The following text was inadvertently included in the article title: ‘Characters: 102(<120)’.This has been corrected with this correction. The original article has been updated. …
Metadata
Title
Correction: Comparing Predictability of Non‑invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients
Authors
Yen-Chun Liu
Ya-Ting Cheng
Yi-Cheng Chen
Yi-Chung Hsieh
Wen-Juei Jeng
Chun-Yen Lin
Rong-Nan Chien
Dar-In Tai
I.-Shyan Sheen
Publication date
17-10-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07683-6

Other articles of this Issue 2/2023

Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease

Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C

Rising Rates of Severe Obesity in Adults Younger Than 50 Correspond to Rise in Hospitalizations for Non-malignant Gastrointestinal Disease

Worsened Fibrostenotic Outcomes in Eosinophilic Esophagitis Patients Due to COVID-19-Related Endoscopy Cancellations

Infections in Acute Pancreatitis: Organisms, Resistance-Patterns and Effect on Mortality

A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more
Image Credits